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1. Introduction 
Abdominal aortic aneurysm (AAA) derives from Greek αǎєυρυσǍα (aneurusma), meaning 
widening, and can defined as a permanent and irreversible dilatation of a vessel. In 1991 the 
Society for vascular Surgery proposed as a criterion that the infra renal aorta diameter 
should be 1.5 times the expected normal diameter. In Europe it is defined as an abdominal 
aorta greater than 30mm. AAA is assumed to be prevalent in about 4% of males over the age 
of 65 although variation exists across countries and cause 1.3% of all deaths among men 
aged 65-85 years in developed countries (Best VA et al.2000). Whether detected incidentally 
or by screening patients with an AAA ≥ 50 mm will be referred for surgical evaluation in 
Denmark. Patients detected with aneurysms below the threshold value for referral to 
surgery will be followed regularly and referred for surgery if their aneurysm grows or if 
they develop symptoms. Patients with symptomatic or ruptured AAA will be referred for 
acute surgery where, in some cases of rupture, the patient will die before reaching the 
hospital (vascular department). A proportion of patients will be unfit for surgery for 
anatomical or physiological reasons while another proportion will decline to have surgical / 
endovascular treatment. Until recent years, open surgery was primarily performed but the 
technique of endovascular aortic repair (EVAR) has now become a part of standard practice 
in many countries. The availability of EVAR is an important alternative for two reasons: it is 
less invasive and it is provides a treatment opportunity for a proportion of these patients 
who are ineligible for open surgery. The natural disease history is progressive and may 
result in rupture with an associated mortality risk of up to 80%.If an AAA on the other hand 
is detected at an earlier, asymptomatic state there will be treatment modalities reducing the 
mortality risk dramatically. An increased awareness of the characteristics of AAA by first 
contact practitioners might reduce the risk of a fatal outcome with this disorder. In this 
chapter, we aim to provide and update review of the decision making in regard to elective 
and rupture treatment of AAA.  
2. Indication for elective treatment 
Although surgical treatment of non-rupture AAA relies on specific rare indications, such as 
distal embolisation, urethral compression, contain rupture, mycotic aneurysm, treatment of 
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intact AAA is essentially prophylactic and aimed at prevention of fatal rupture. The 
expected functional form of the relationship between risk of rupture and size, it would be 
appropriate to model relatively small size-intervals for larger aneurysms. Data availability 
on growth and rupture rates remain limited due to patients being repaired once their 
aneurysm reaches 55 mm, unless they are unfit or unwilling to receive surgical treatment. It 
was decided by Morkov  model, that  the disease process using starting states: definitely no 
AAA (0-25mm), probably no AAA (25-29mm), small or medium –sized AAA with 
essentially no risk of rupture (30-49mm), medium–sized AAA close to the iatrogenic 
threshold (50-54 mm) and four states of large AAAs above the iatrogenic threshold (55-59 
mm., 60-69 mm., 70-79 mm. and 80+ mm.). Figure 1 shows the proposed model structure for 
which the underlying decision pathways and structural assumptions are detailed in the 
following. The choice of Markov model implies two overall assumptions. First, the so-calls 
Markova property states that individuals starting in a given state can be modelled in the 
same way. This means that the route to arriving in a state or time spend in a state has no 
influence on subsequent parameters. For example, when individuals arrive at acute open 
surgery their probability for a successful outcome is independent on whether symptoms 
arose from 30 mm or a 70 mm AAA. Second, the so-called stationary assumption states that 
parameters are time–homogeneous, and do not vary from one cycle to another. There are 
limited opportunities for relating assumption, which in the present context were taken 
advantage of to allow increasing mortality rates as population age. 
 
 
Note: Blue ovals represent starting states. All numbers refer to abdominal diameter in millimetres. The 
model structure was applied equally for a scenario with and a scenarario without screening EVAR= 
elective endovascular vascular aortic repair. FU= folllow up. AAA= Aortic abdominal aneurysm. 
Fig. 1. Markov model for the course of abdominal aortic aneurysms 
The starting states of AAAs above the threshold for eligibility for elective surgery share the 
same decision pathway, except that ≥ 80 mm cannot grow to the next state. If the aneurysm 
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is symptomatic they will be referred to acute surgery following a similar protocol as 
described for the 55-59 mm AAA whereas if non-symptomatic, they will either be detected 
and referred for elective surgery or remain undetected in the state ( if no growth) or in the 
next disease state ( If growth). The size of the abdominal aneurysm is a universally 
recognised factor to forecast rupture, and the general consensus is that patients with a large 
aneurysm >5.5 cm should undergo surgical treatment. The real controversy surrounds the 
management of small aneurysm and large aneurysm in unfit patients. Indication for surgical 
treatment is deduced from the estimated risk of rupture, the estimated risk of the surgical 
procedure, and the estimated life expectancy of the patient. Fig 2: shows proposed 
management plan for asymptomatic abdominal aortic aneurysms. To be most effective, it 
should be performed when the rupture risk is high compared with operative risk, in 
patients who will live long enough to enjoy the long term benefit. It is assumed the elective 
treatment should be offered without waiting time (since there is no option for rupture while 
waiting for surgery). In practice, elective surgical treatment might not offered on the same 
days as indicated but give a 30 –day treatment guarantee in the Danish health care system 
and discretion of surgeons to prioritize the most sever candidates first this seemed a 
justified assumption in order to moderate the complexity of model structure.  
 
 
Fig. 2. proposed management of an asymptomatic abdominal aortic aneurysm. EVAR = 
endovascular repair of AAA. 
2.1 Risk of elective aneurysm repair 
Reported mortality rate related to elective AAA repair varies among hospitals and surgeons. 
Mean 30-days mortality rate has been reported between 1.1% and 7.0% (S. Shahidi et al. 
2008). Randomized EVAR 1 showed the overall 30days mortality, regardless of the risk 
factors after open surgery and endovascular repair (EVAR) was 4.6% and 1.5%, 
respectively.In 2009 the overall 30-days mortality rate in Denmark was 2.7% out of 310 open 
surgeries and 2.1% out of 196 EVAR. (www.karbase.dk). Most deaths resulting from the 
repair occurred in the so called high-risk patient. Factors of increased operative risk are 
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renal failure, chronic obstructive pulmonary disease, and most importantly myocardial 
ischemia. In this matter, analysis of the EVAR 2 trial data performed by the EVAR 
investigators did not show a significant difference in either all-cause or aneurysm-related 
mortality. Thus, outcomes of the EVAR 2 trial have not settled the choice between EVAR 
and no treatment in this scenario to everyone's satisfaction. In patients with large AAAs 
who are fit for open surgery, EVAR offers an initial mortality advantage over open, with a 
persistent reduction in AAA-related death at 4 years. However, EVAR offers no overall 
survival benefit, is more costly, and requires more interventions and indefinite surveillance 
with only a brief QOL benefit. It may or may not offer a mortality benefit over non-operative 
management in patients with large AAAs who are unfit for open repair, but the statistical 
significance of this comparison is inconclusive. In relation to growth rate /year, there will 
always be a relative concentration of patients unfit for open surgery in the follow-up 
program. It is thus assume that the risk of rupture is not affected from that and the high risk 
patients individually should spotted in the matter of rupture risk/ year and the risk of 
open/ EVAR treatment, if this is technically possible and acceptable. Patients, who have a 
very low restricted life expectancy estimated (0-4) year, suggest treating by non-operative 
management.  
3. Rupture abdominal aorta aneurysm, transition to AAA-related death 
Related death is defined as consequence of rupture or as consequence of undergoing 
surgery if death occurs within 30 days postoperatively. A certain proportion of patients with 
rupture will not reach the hospital alive for emergency surgery. Most patients (92%) with a 
rupture who reach the vascular clinic alive have a rupture of the posterolateral wall into the 
retroperitoneal space. Banke A et al, 2008.  
3.1 Risk of rupture 
The UK small aneurysm Trial 1998 and the US Veterans Administration study led to similar 
findings despite a lower operative mortality 2.7% vs.5.8%). The conclusion was, infra 
abdominal aorta aneurysms smaller than 5.5 cm in diameter is safe, where as early surgery 
is not associated with improved long-term survival. Today it is accepted that AAA diameter 
is the best predictor of rupture risk. The variability of estimates of rupture risk for particular 
AAA diameters cited in the literature reflects differences in other factors besides maximal 
diameter which may vary considerably from series to series, and illustrates that other factors 
in addition to absolute size must be taken into account in each individual case. It is clear that 
there is a substantial increase in rupture risk as AAA diameter increase from 5 cm to 6 cm. ( 
Nevit et al., 1989) reported no rupture during 5-years follow-up for AAA < 5 cm, but a 5% 
annual rupture risk for AAA> 5 cm at initial presentation. Similar estimates were obtained 
from the larger UK Small aneurysm Trial, where the annual rupture to be 0% (0-5%) for 
AAA< 4 cm. The long-term report from the UK small aneurysm has shown that the risk of 
rupture in women was nearly four times higher than in men. The studies of rapid expansion 
of AAA suggest the size of AAA is probably not the sole useful determinant for risk of 
rupture (Limet et al., 1991 & Gilmaker et al., 1991). Active investigations have been and still 
are being done to identify markers other than size that would predict a risk of rupture. The 
level of serum MMP-9 has been reported to be significantly higher in patients with AAA 
and also associated with the size expansion rate of these AAA (Sakalihasan et al., 1996). 
www.intechopen.com
 
Abdominal Aortic Aneurysm (AAA): The Decision Pathway in Ruptured and Non-Ruptured AAA 
 
61 
Preliminary data obtained by PET Imaging of AAA have shown focal uptake of (18 F-FDG) is 
regarded as a functional image of inflammatory response and thus as a potential non-
invasive technique to identify unstable AAA that are prone to rupture Sakalihasan et al, 
2002. Probabilities of rupture were estimated from the literature. Estimates generated before 
year 2000 were considered to be outdated due to the introduction of medical treatment 
(Statin) in the beginning of 1990. After close examination of studies, the EVAR II was 
excluded since only patients fit for EVAR were included. Table 1 shows the estimated risk of 
rupture in AAA, as the function of AAA diameter size in centimetre.  
 
AAA diameter size, (cm) Rupture risk /year 
4,0-4,9 0,5-5,0% 
5,0-5,9 3-15 % 
6,0-6,9 10-20 % 
7,0-7,9 20-40 % 
Over 8 30-50 % 
Table 1. Estimated annual rupture risk in AAA.  
The simple observation that not all AAAs rupture at a specific diameter indicates that other 
patient- or aneurysm-variable also effect rupture risk. The risk of rupture is also correlated 
with co-morbidities as age, lung disease COPD,blood pressure, cardial disease, diabetes. The 
probability for rupture among high risk patients who are inoperable is likely to be higher 
than the equivalent in aneurysm-size matched patients. No estimates of ruptures in the 
group of high risk patients were found to be available in literature. Important information 
concerning AAA rupture from the UK Small Aneurysm Trial was that patients with 4.0-5.5 
cm AAAs , the relative risk of rupture was independently increased by female gender (3.0x), 
larger initial diameter (2.9x per cm.), current smoking (1,5x), age (1,3x per 4 years), worse 
COPD (0.6x per L ,FEVI), and higher mean arterial pressure ( 1.02x per mmHg). In addition 
to AAA size, many surgeons consider the ratio of diameter to the proximal normal aorta, a 5 
cm. AAA in a patient with a 1.5 cm native aortic diameter may or may not to be at greater 
risk of rupture compared with the same size AAA in a patient with a native aortic of 2.5 cm. 
The validity of this concept, however has not been proven. The relative comparison between 
aortic diameter and the diameter of the third lumbar vertebra reported to increase the 
accuracy for predicting rupture risk, by adjusting for differences in body size (Ouriel et al., 
1992). The improvement in prediction accuracy appears minimal, however, when compared 
with absolute AAA diameter. Although rapid AAA expansion is presumed to increase 
rupture risk, it is difficult to separate this effect from influence of expansion rate on absolute 
diameter, which alone could increase rupture risk. 
3.2 Open emergency repair of AAA 
The selection of patients with ruptured abdominal aortic aneurysms (RAAAs) for 
emergency repair can be a complex and emotionally charged process. Two possible broad 
approaches to patients with RAAA exist: an ‘‘all-comers’’ approach and a more ‘‘selective’’ 
approach. The all-comers approach offers surgical intervention in every patient, regardless 
of current status or presence of significant co morbidities. The selective approach would 
involve an assessment of operative risk predictors and co morbidities in an attempt to 
identify patients with an unrealistic expectation of a successful outcome. The epidemiology 
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of AAA is changing. (Best et al., 2000) reported a persistent increase in the incidence of 
emergency AAA with an associated increase in age-adjusted AAA mortality. The recorded 
incidence of RAAA varies from region to region in Denmark. The national incidence of 
operated AAA and RAAA per year has increased in the last 10 years in Denmark: That for 
operated elective AAA is 6 to 7/100,000 and that for RAAA is 3.5 to 6/100,000 populations 
(S. Shahidi et al., 2009). 
Despite recent advances in anaesthetic, operative, and postoperative care, the high mortality 
figure has prompted many surgeons to question whether repairing RAAA should even be 
attempted in the subset of patients with poor physiological reserve. Although some decline 
has been reported over the years, the overall operative mortality is still in the range of 40-
50% (Fig.3). Elderly patients have a restricted life expectancy. In Denmark in 2005-2006, life 
expectancy for males aged 60, 65, 70, 75, 80, and 85 years old was 18,15.5, 11, 5, 6, and 4.8 
years, respective (S. Shahidi et al., 2009). For patients who undergo AAA repair, the 5-year 
survival rate is reduced compared to age and matched individuals (60-65%) (Barlow AP et 
al, .1989). Excess mortality in this patient group is substantially attributable to associated co 
morbidities, particularly coronary artery disease. In order to make this difficult decision 
more objective, a number of scoring systems have been constructed; however, none of them 
focuses on practical scores, which can be calculated preoperatively in an elderly surgical 
patient with RAAA. Is it pointless to operate on an elderly patient with RAAA? Can we 
exclude such patients from RAAA treatment? What should we do with elderly patients with 
RAAA? 
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Fig. 3. Overall operative mortality after RAAA compared to background population, shows 
40-50% survival reduction in the first 30 days after rupture (www.karbase.dk). 
However, repair of RAAA in the elderly generally requires a careful assessment of life 
expectancy and of the impact of repair-related complications in this specific high-risk subset 
of patients. It may be still question, if would repair really be the best solution for the elderly 
patient? Should the patient be palliated? Would the resources we need to use be correctly 
addressed? These rhetorical questions and issues pose an increasing challenge and 
discussion for vascular-surgeons. In this respect, ethical problems and cost analysis can be 
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important components in the decision-making process. Some might claim that the health 
economy aspects are hardly relevant or that health economy has nothing to do with 
decision-making concerning the individual patient (at least not yet). Furthermore, some are 
of the opinion that the cost incurred during prolonged intensive treatment of elderly 
patients is substantial and that these resources, ideally, should not be wasted on futile 
endeavours. Currently, as clinicians are increasingly required to accept fiscal autonomy and 
budgetary responsibility, it is important that the use of health-care resources benefits not 
only the individual patient but also the wider group of all patients attempting to gain access 
to health care. This managerial role involves an increasing awareness of cost restraints 
within the health service, an awareness of the pressure to rationalize limited resources, and 
the need for awareness both in Denmark and worldwide of the realistic outcomes of a 
proposed treatment option. 
 
 
Fig. 4. Thirty-day mortality and survival after open repair of RAAA in the regions of age 
groups1:  S. Shahidi et al, 2009. 
In 2005, the policy of our department was to operate on all patients with an RAAA who 
reached the hospital alive, who did not refuse surgery, and who did not have a severe 
terminal malignancy. In some institutions, patients are selected for repair after consideration 
of age, presentation, and medical co morbidities. A recent survey showed that 97% of U.K. 
vascular surgeons practice a selective approach (Hewin DF et al., 1998). Many reports have 
attempted to identify independent predictors for mortality, but there is no ideal scoring 
system for preoperative assessment of elderly patients needing emergency RAAA surgery 
(Al Omran et al, 2004, S. Shahidi et al., 2009, 2010). Some preoperative scoring systems 
www.intechopen.com
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
64
provide approximate estimates of mortality risk, but none has proved sufficiently specific 
for use on elderly individuals. Among the 72 cases of infra- and juxtarenal open RAAA 
repair, 30-day mortality was markedly skewed around a median age in the region of 75-79 
years. The number of procedures in the different age groups according to 30-day mortality is 
presented in Figure 3. 2009. Out of 28 elderly patients (39%), eight (11%) were 75-80 years of 
age and 20 (28%) were aged 80 or more. The 30-day mortality was 75% for patients 75-80 
years of age and 50% for patients aged 80 years or more. The 30-day mortality rates for 
patients in the elderly group was 16 (57%, CI 48-72%), significantly higher than the mortality 
rate of 9 (20%, CI 12- 33%) in the younger group (p < 0.001) (Table 2). 
The significant risk factors identified by univariate analysis were then used in a multivariate 
analysis by means of simple logistic regression with death as the outcome to predict 
mortality. The logistic regression analysis was repeated to find significant independent risk 
factors in the elderly compared to the younger groups. As illustrated in Table 2, age ≥75 and 
creatinine level ≥0.150 mmol/L were the only significant (p <0.05) risk factors in the present 
study. 
 
 
 
Table 2. Multivariate analysis of 30 days mortality from (S. Shahidi et al; 2009). 
In this study the age range for 30-day mortality was a markedly skewed distribution around 
a median age in the region of 75-80 years (Fig. 1). The ROC analysis in our series showed 
that the age of 75 years gave the greatest area under the curve for predicting 30-day death 
postoperatively (a cut-off age). Of course, the sample size is small and this would be a bias; 
but with the above studies and the life expectancy of Danish males in mind, our study 
suggests that a male patient aged 75 years or more with an RAAA should be considered 
elderly. There are some other risk score systems.  
In another study, we compared of preoperative levels of Base deficit and Lactate in 
predicting outcome in patients with open repair after RAAA (S. Shahidi et al,. 2010). From 
January 2006 to December 2008, the medical records of 47 patients with RAAA were 
reviewed. Of the 47 patients enrolled in the study, 44 were men and 3 were women, with a 
median age of 71 (CI: 69-73), at admission. Patient’s demographics and underlying co-
morbidities are listed in Table 3. Twenty-five (53%) patients died within 30 days in the per-
operative period. Altogether, there were twelve (26%) on-table deaths; five (11%) patients 
died within 24 hours after surgery; 8 (17%) patients died of multi-organ failure. Survivors 
had a median age of 70(range 40-83), which is significantly younger than non-survivors 
75(range 59-85) (p=0.009). Pre-operative lactate (p=0.011), pre-operative base deficit 
(p<0.001), measured blood loss (p=0.002) are significant higher in non-survivors compared 
with survivors. These data suggest that pre-operative base deficit is a valuable marker better 
than pre-operative lactate for the identification of the per-operative death of patients with 
ruptured AAA. A threshold of level of -4.0 mmol/L of pre-operative base deficit had the 
highest combined sensitivity and specificity for the identification of per-operative death 
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after repair of ruptured AAA. The sensitivity and specificity of pre-operative base deficit <-4 
mmol/L was 80.0% and 86.3%, respectively. 
Receiver-operating-characteristic (ROC) curves were constructed to illustrate various cut-off 
values of pre-operative lactate, and base deficit. The mean ± SE area under the receiver-
operating-characteristic curve for pre-operative base deficit was 0.83±0.06 (95% confidence 
interval 0.71 to 0.95, p<0.001) among non-survivors. Pre-operative lactate level had a mean 
area under the curve of 0.72±0.08 (95% confidence interval 0.57 to 0.87, p=0.011) among non-
survivors. A cut-off value of -4 mmol/L of pre-operative base deficit has 80.0% sensitivity 
and 86.3% specificity respectively 
 
 
Table 3. Clinical variables in survivors and no survivors after open RAAA repair. 
 
 
Fig. 4. ROC analysys curve for base  
difficiet in our study. 
Fig. 5. Roc analysis curve for lactat in our 
study 
Fig. 4 & 5. Receiver operating characteristic curves of preoperative lactate (black), and base 
deficit (red).  
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4. Health economic finance 
The financing of Danish hospitals is through the national Diagnostic Related Group (DRG 
system). DRG is classified by diagnosis and surgical procedure according to this system and 
gives a value estimated by Danish health authorities. Since the majority of the procedures 
were complicated, the DRG with recorded complications was used. Based on these DRG 
values, the cost of each of the 30 days gained from surgical repair in these elderly patients 
could be estimated. The DRG value for the year 2005 was used for all patients. DRG is the 
average expenses, which depends on two parameters of the ICD-9 diagnosis, e.g., I.713 
(RAAA), and the treatment, e.g., KPDG10 (operation for AAA). The average estimated cost 
of in-hospital treatment of RAAA was €15,350 (DRG) in 2005 in Denmark In 2005, the 
Danish health authorities estimated the average cost of an operation for RAAA to be €15,350 
DRG compared to an elective AAA, which is €8,500 DRG. Concerning the age 75 years, our 
data show that the respective risk difference (RD) is approximately 0.38 (0.157-0.575), with 
an estimated NNT of 2.0 (1.74-6.34) (S. Shahidi et al., 2009). 
5. Discussion 
Decision-making in regard to elective repair of AAA requires careful assessment of factors 
that influence rupture risk, operative mortality and life expectancy. Individualizes 
consideration of these factors in each patient in each patient is essential, and role of patient 
preference is of increasing importance. The surgeon should be very aware that the elective 
treatment of AAA in every case and in any time is only a prophylactic treatment. It is not 
possible or appropriate to recommend a single threshold diameter for intervention which 
can be generalized to all patients. Based upon the best  available current evidence, 5.5 cm is 
the best threshold for repair in an “average” patient. However, subsets of younger, good-
risk patients or aneurysms at higher rupture risk may be identified in whom repair at 
smaller sizes id justified. I do believe that delaying in repair until larger diameter may be 
best for older, higher-risk patients, especially if endovascular repair is not possible. 
Intervention at diameter < 5.5 cm appears indicated in women with AAA and maybe in 
patients with rapid AAAs expansion. If a patient has suitable anatomy , endovascular repair 
should be considered, and it is most advantageous for older, higher-risk patients, who has 
acceptable life expectancy. The patient with a very low life expectancy should not under-go 
an invasive prophylactic repair. There is evidence for EVAR clearly reduced perioperative 
mortality, morbidity and recovery time, however, there is a higher reintervention rate, 
increased surveillance burden, and a small but ongoing risk of AAA rupture. In my 
knowledge there is no justification at present for different indications for EVAR , such as 
earlier treatment of smaller AAA. We are still waiting for long-term outcome of 
endoluminal repair is better defined and results of randamized trials available, the choice 
between EVAR and Open repair will continue heavily on patient preference and 
information.       
In the matter of RAAA and emergency repair of RAAA, there are many reports , as the 
report from the Mayo Clinic showed that advanced age, high Acute Physiology and Chronic 
Health Evaluation (APACHE II) score, low initial hematocrite, and preoperative cardiac 
arrest increased mortality rates (Goffi et al,. 1999). The APACHEII is commonly used to 
assess surgical patients in the ICU, where it was designed to predict outcome, but has 
seldom been used in preoperative assessment. The APACHE II scores appear to predict 
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outcome equally well when the age points are omitted. Goffi concluded that fit elderly 
persons should not be denied an emergency operation because of their age alone. (Hardman 
et al,. 1996) reviewed 154 patients and identified five independent preoperative risk factors 
that were associated with mortality: age >76 years, an ischemia electroencephalogram, Hb 
<9 g/dL, creatinine >0.19 mmol/L, and loss of consciousness. They also reported that all 
patients who presented three or more variables died. In addition, (Johnston et al., 1994) 
found that hypotensive patients with raised creatinine had only a 20% chance of survival. 
The Glasgow Aneurysm Score (GAS), first described in 1994, calculated a risk of mortality 
with RAAA using age in years: +17 for the presence of shock, +7 for myocardial disease, +10 
for cerebrovasculare disease, and +14 for renal disease (Sammy ak et al.). All of these 
findings strongly suggest that mortality is determined by the severity of physiological insult 
and the patient’s premorbid physiological reserve. Despite the findings of our studies and 
other studies, there is still no consensus on how to use these preoperative variables. While 
these clinical variables may prove useful, they must be interpreted with caution and should 
only act as an adjunct to clinical decision-making. A ruptured aneurysm is lethal in almost 
every case, unless the patient is operated successfully (Olsen P et al., 1991). That is why the 
scoring system should be able to differentiate those elderly patients who have no chance of 
survival from those who are likely to benefit from surgery (S. Shahidi et al., 2009 and 2010). 
The estimated cost per life after 30 days postoperatively was €40,409 (DRG) for the elderly 
patient in our cohort in 2005 compared to €18,880 (DRG) in the younger group. This can be 
compared to the cost per year of life gained by haemodialysis, which is estimated to be at 
least €50,000 (Winkel M.et al., 1999). Regarding the health economic aspect in RAAA 
patients, we found only one study. An interesting Norwegian study showed the total 
survival time of octogenarians treated for RAAA. Over a 20-year period, 53 patients aged 80 
years or older were operated for RAAA. The survival time was estimated and related to 
DRG values in order to estimate the cost of each year of life gained by operating on this type 
of patient (Aune et al., 2004). The authors concluded that the operative mortality for patients 
aged >80 years with RAAA is high (47%) but the price of each gained year of life is relatively 
low. The estimated cost per gained year of life was € 6,817. The accurate cost of each 
operation obviously varies and is difficult to calculate. That is why we have based our 
calculation on the DRG cost. There is some evidence of a significant reduction in mortality 
from AAA in men aged 65-79 years who undergo ultrasound screening. The cost-
effectiveness may be acceptable but needs further expert analysis (Mass study 2002). A Cost 
effectiveness analysis based on a probabilistic, enhanced economic decision analytical model 
from screening to death (MTV report) from Denmark(showed the estimated costs per 
quality adjusted life year (QALY) gained discounted at 3% per year over a lifetime for costs 
and QALYs was £43 485 (£54 852; £71 160). At a willingness to pay threshold of £30 000 
the probability of screening for abdominal aortic aneurysm being cost effective was less than 
30%. One way sensitivity analyses showed the incremental cost effectiveness ratio varying 
from £32 640 to £66 001 per QALY. Ehlers concluded screening for abdominal aortic 
aneurysm does not seem to be cost effective. Further research is needed on long term quality 
of life outcomes and costs (Ehlers et al., 2008). These findings still need careful consideration 
in judging whether a co-coordinated population-based screening program should be 
introduced. The screening program has been implemented in United Kingdom. In Denmark 
we are waiting for further expert analysis and approval from the Danish health authorities. 
The screening program would be discussed in other chapters. Open repair is still the 
predominant procedure for RAAA. Until today, there has been no high-quality evidence to 
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support the use of (EVAR) in the treatment of RAAA. However, evidence from prospective 
controlled studies without randomization, prospective studies, and retrospective case series 
suggests that EVAR is feasible in selected patients, with outcomes comparable to best 
conventional open surgical repair for the treatment of RAAA (AJAX trial still going on). The 
numbers of EVAR procedures for this group are small in Europe. The second VASCUNET 
data-base report from 2008 for 10 year operative outcome of more than 33.000 patients with 
aortic aneurysms in six countries, Denmark (DK), England (UK), New Zealand (NZ), 
Australia (AST), Sweden (SW) and Switzerland (SWZ), with participating of 202 hospitals, 
showed a much less use of EVAR in RAAA in these countries. The percentage of operation 
type according RAAA and EVAR in these six countries until 2009 was DK=1, UK=4, NZ= 7, 
SW= 22, AST=8 and SWZ=21 of all ruptures (S. Shahidi et al., 2009). The promising results 
for EVAR of ruptured abdominal aneurysms may have the potential to significantly lower 
the mortality in all RAAA patients. That is why the author suggest, all elderly high risk 
patients, patient with preoperative renal dysfunction and pre-operative base deficit < -
4mmol/L should be selected to EVAR, if this is technically possible. Had we chosen not to 
operate on elderly patients with preoperative serum creatinine 0.150 mmol/L, or elderly 
patients with a basis deficit -4.0 mol/ l, at least eleven patients would have been denied a 
life-saving operation. All of these eleven patients were successfully discharged from 
hospital (S. Shahidi et al., 2009 & 2010; Banke A., 2008). 
6. Conclusion and future 
The arbitrary setting of a single threshold diameter for elective AAA repair applicable to all 
patients is not appropriate, as the decision for repair must be individualized in each case.  
The most important thing in individual decision-making of this elective prophylactic 
treatment is the estimated risk of rupture, the estimated risk of the surgical procedure, and 
the estimated life expectancy of the individual case, and giving the competence to the out- 
patients for making decision along with the surgeon.  
 The ideal treatment of RAAA is prevention or to increase the probability of reaching 
hospital alive in case of rupture. In our experience, after 1-year follow-up, open repair has 
been life-saving in 77% of patients younger than 75 years, with a low price estimated at € 
18,880, and surgical repair has been life-saving in 33%of patients aged 75 years and older at 
a relatively low price for each life, estimated at € 40,409. The first goal in abdominal aortic 
aneurysm still is the prevention of rupture; hopefully the next aim in the future will be the 
prevention of abdominal aortic growth. 
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